Equities

Amrutanjan Health Care Ltd

AMRUTANJAN:NSI

Amrutanjan Health Care Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)801.50
  • Today's Change20.50 / 2.62%
  • Shares traded31.12k
  • 1 Year change+27.20%
  • Beta1.0572
Data delayed at least 15 minutes, as of Sep 20 2024 11:17 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue4,2123,7964,058
OPERATING EXPENSES
Cost of revenue total2,1571,8501,831
Selling, general and admin. expenses, total1,0961,0951,429
Depreciation/amortization615238
Unusual expense(income)6.48----
Other operating expenses, total4324053.02
Total operating expense3,7523,4033,302
Operating income460394757
Other, net132538
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes619536906
Provision for income taxes170138234
Net income after taxes450398672
Minority interest------
Net income before extra. Items450398672
Total extraordinary items------
Net income450398672
Inc.avail. to common excl. extra. Items450398672
Inc.avail. to common incl. extra. Items450398672
EPS RECONCILIATION
Basic/primary weighted average shares292929
Basic/primary eps excl. extra items151423
Basic/primary eps incl. extra items151423
Dilution adjustment------
Diluted weighted average shares292929
Diluted eps excl. extra items151423
Diluted eps incl. extra items151423
COMMON STOCK DIVIDENDS
DPS - common stock primary issue4.604.604.60
Gross dividend - common stock13313476
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental1.570.772.30
SUPPLEMENTAL INCOME
Depreciation, supplemental524437
Total special items6.02(0.27)0
NORMALISED INCOME
Normalized income before taxes625536906
Effect of special items on income taxes1.65(0.07)0
Income tax excluding impact of special items171138234
Normalized income after tax454398672
Normalized income avail. to common454398672
Basic normalized EPS161423
Diluted normalized EPS161423
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.